Drugs in Dev.
Infections and Infectious Diseases
Discovery
Israel 
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Discovery
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Kamada plans to initiate the development of an Anti-Corona polyclonal immunoglobulin using its proprietary plasma derived IgG platform technology for severely ill coronavirus patients.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
March 11, 2020
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Discovery
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
